Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-06

Clinical Trial Update: MYnd Analytics Directed Therapy in Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for MYnd Analytics Directed Therapy in depression, sponsored by Cota Inc.; the current trial status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYnd Analytics Directed Therapy

Snippet

Sponsor: Cota Inc. | Conditions: Depression | Phase 4 | Status: UNKNOWN